1
|
Wang Y, Wang X, Yang Y, Quan Q, Huo T, Yang S, Ju R, An Q. Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone. Clin Cosmet Investig Dermatol 2022; 15:1959-1967. [PMID: 36159203 PMCID: PMC9491233 DOI: 10.2147/ccid.s378798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 09/05/2022] [Indexed: 11/23/2022]
Abstract
Background Cannabidiol (CBD) is a non-psychoactive phytocannabinoid constituent of Cannabis sativa with pain-relieving and anti-inflammatory properties. With the emphasis on natural ingredients in cosmetics, CBD has become a new cosmetic ingredient due to its ability to alleviate inflammation. However, in-depth studies that directly compare the effective mechanism and the therapeutic potential of CBD are still needed. Purpose The aim of the present study was to investigate the anti-inflammatory effect of CBD in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and compare it to dexamethasone (DEX). Methods RAW264.7 macrophages in the logarithmic growth phase were incubated in the presence or absence of LPS. After that, the production of nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were measured. A luciferase reporter assay for nuclear factor kappa B (NF-κB) was performed, and the phosphorylation levels of the mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways were measured. Results The present study indicated that CBD had a similar anti-inflammatory effect to DEX by attenuating the LPS-induced production of NO, IL-6, and TNF-α. However, only CBD attenuated JNK phosphorylation levels, and only DEX attenuated IKK phosphorylation levels. Conclusion These results suggested that CBD and DEX exhibit similar anti-inflammatory effects on LPS-induced RAW264.7 macrophages mainly through suppressing the MAPK and NF-κB signaling pathways, but with different intracellular mechanisms. These findings suggested that CBD may be considered a natural anti-inflammatory agent for protecting skin from immune disorders.
Collapse
Affiliation(s)
- Yiming Wang
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China
| | - Xue Wang
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China
| | - Yang Yang
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China
| | - Qianghua Quan
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China
| | - Tong Huo
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China
| | - Simin Yang
- Beijing Key Laboratory of Enze Biomass Fine Chemicals, Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, People's Republic of China
| | - Ruijun Ju
- Beijing Key Laboratory of Enze Biomass Fine Chemicals, Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, People's Republic of China
| | - Quan An
- Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China.,East Asia Skin Health Research Center, Beijing, People's Republic of China.,Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China.,Research and Development Department, Yunnan Baiyao Group Shanghai Science & Technology Co, Ltd, Shanghai, People's Republic of China
| |
Collapse
|